98%
921
2 minutes
20
Hearing loss (HL) is a prevalent health issue, and identifying noninvasive biomarkers for early detection is crucial. This study investigates the association between retinal vascular fractal dimension (FD) and HL in a health checkup population. A retrospective cross-sectional study was conducted with 575 participants who underwent ophthalmological and audiological assessments at Shanghai Health and Medical Center CN between October 2014 and January 2024. Retinal FD was measured using nonmydriatic fundus photography and analyzed using Singapore I Vessel Assessment software. Hearing thresholds were assessed by air-conduction pure-tone audiometry, with the high Fletcher index (hFI) used to evaluate hearing acuity. Results showed that higher retinal FD values were significantly associated with better hearing acuity. Specifically, each 1-SD increase in arteriolar FD (FDa) was correlated with a 2.85 dB decrease in the hearing threshold at 1 kHz (β = -2.85, 95% CI - 4.47 to - 1.23, p < .001), and each 1-SD increase in venular FD (FDv) was correlated with a 2.61 dB decrease at 2 kHz (β = -2.61, 95% CI - 4.42 to - 0.80, p = .005). The study suggests that retinal FD may serve as a noninvasive biomarker for early detection of HL and could assist in the development of preventive strategies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12365288 | PMC |
http://dx.doi.org/10.1038/s41598-025-16451-1 | DOI Listing |
Invest Ophthalmol Vis Sci
September 2025
Department of Ophthalmology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, China.
Purpose: To explore the causal links between antihypertension drugs usage and age-related macular degeneration (AMD).
Methods: Multiple genetic analyses, including summary data-based Mendelian randomization (SMR), traditional MR, and colocalization analysis, were used to explore the causal associations between antihypertension drugs and AMD. Clinical data from the UK Biobank and the National Health and Nutrition Examination Survey (NHANES) was applied to refined risk assessment of specific antihypertensive medications in the context of AMD development.
Mol Ther Methods Clin Dev
June 2025
Shanghai Vitalgen BioPharma Co., Ltd., Shanghai 201210, China.
Bietti crystalline dystrophy (BCD) is an autosomal recessive disorder caused by loss-of-function mutations in the gene, characterized by crystal-like lipid deposits in the retina, progressive photoreceptor loss, and retinal pigment epithelium (RPE) deterioration. Currently, there are no approved treatments for BCD. VGR-R01, an investigational gene therapy, uses subretinal administration of recombinant adeno-associated virus type 8 (AAV8) vector to deliver the human CYP4V2 gene.
View Article and Find Full Text PDFFront Cell Neurosci
August 2025
Stem Cell Research Center, University of California, Irvine, Irvine, CA, United States.
Objective: To assess the safety and tolerability of intravitreal injection of human retinal progenitor cells (RPCs) at multiple dose levels in adults with non-syndromic retinitis pigmentosa (RP).
Design: A prospective, multicenter, open-label, single-arm, Phase I/IIa safety study of RPCs in adults with RP ( = 28). Two patient cohorts were studied: Cohort 1: BCVA no better than 20/200 and no worse than Hand Motions, and Cohort 2: BCVA no better than 20/40 and no worse than 20/200).
Am J Case Rep
September 2025
Department of Ophthalmology, University Medical Center Ljubljana, Ljubljana, Slovenia.
BACKGROUND Central retinal vein occlusion (CRVO) is associated with cardiovascular risk factors, but hypercoagulability, endothelial dysfunction, and stasis of blood present in patients with chronic obstructive pulmonary disease (COPD) may also play a role in its pathogenesis. This report describes the case of a 70-year-old woman who presented with reduced vision in the right eye due to CRVO. CASE REPORT A 70-year-old woman with a history of smoking presented with decreased vision in the right eye.
View Article and Find Full Text PDFBMC Mol Cell Biol
September 2025
School of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK.
Retinitis pigmentosa (RP) affects around 1 in 4000 individuals and represents approximately 25% of cases of vision loss in adults, through death of retinal rod and cone photoreceptor cells. It remains a largely untreatable disease, and research is needed to identify potential targets for therapy. Mutations in 94 different genes have been identified as causing RP, including AGBL5 which encodes the main deglutamylase that regulates and maintains functional levels of cilia tubulin glutamylation, which is essential to initiate ciliogenesis, maintain cilia stability and motility.
View Article and Find Full Text PDF